Identification and validation of plasma metabolomics reveal potential biomarkers for coronary heart disease

H Fu, K Zhu, D Zhou, Y Guan, W Li… - International Heart Journal, 2019 - jstage.jst.go.jp
Coronary heart disease (CHD) is a prevalent and chronic life-threatening disease. However,
there is no reliable way for early diagnosis and prevention of CHD so far. The precise …
被引用次数：22 相关文章

Identification and Validation of Plasma Metabolomics Reveal Potential Biomarkers for Coronary Heart Disease

H Fu, K Zhu, D Zhou, Y Guan, W Li… - International Heart Journal, 2019 - jstage.jst.go.jp
Coronary heart disease (CHD) is a prevalent and chronic life-threatening disease. However,
there is no reliable way for early diagnosis and prevention of CHD so far. The precise …

Identification and Validation of Plasma Metabolomics Reveal Potential Biomarkers for Coronary Heart Disease.

H Fu, K Zhu, D Zhou, Y Guan, W Li… - International Heart Journal, 2019 - europepmc.org
Coronary heart disease (CHD) is a prevalent and chronic life-threatening disease. However,
there is no reliable way for early diagnosis and prevention of CHD so far. The precise …

Identification and Validation of Plasma Metabolomics Reveal Potential Biomarkers for Coronary Heart Disease

F Hong, Z Kaibin, Z Daliang, G Yongbin… - International Heart …, 2019 - cir.nii.ac.jp
抄録< p> Coronary heart disease (CHD) is a prevalent and chronic life-threatening disease.
However, there is no reliable way for early diagnosis and prevention of CHD so far. The …

Identification and Validation of Plasma Metabolomics Reveal Potential Biomarkers for Coronary Heart Disease

H Fu, K Zhu, D Zhou, Y Guan… - International heart …, 2019 - pubmed.ncbi.nlm.nih.gov
Coronary heart disease (CHD) is a prevalent and chronic life-threatening disease. However,
there is no reliable way for early diagnosis and prevention of CHD so far. The precise …